Innovative Cancer Blood Testing
Our mission is to advance early cancer detection by providing patients and healthcare providers with cutting-edge, non-invasive blood testing solutions.
Know Your Cancer Risk. Take the Next Step.
No blood draw. No imaging. Get a personalized assessment of your risk across 10 cancers.
Powered by advanced AI with 87.5% predictive accuracy and 91.2% sensitivity, our assessment combines AI technology with insights from 140+ scientific studies.
Receive a personalized report explaining your risk and what screening options to consider next.
Understand your risk. Know what to do next.
For risk assessment and screening guidance only. Not a diagnostic medical device.
United States
The consultation included in your testing package takes place after your initial payment.
It is a brief, pre-test discussion designed to help determine whether the selected blood test is suitable for your general health goals. Please note that this consultation is limited in scope and does not include diagnosis, treatment, or extended medical advice.
Licensed Provider Consultation
After you submit your request for an OkaiDx test, a licensed healthcare provider will review your health information to ensure that the test is appropriate for you. The test will only proceed once a qualified provider has completed this review and confirmed medical suitability.
CLIA＆CAP Accredited Laboratory
OkaiDx is offered as a laboratory-developed test (LDT) by EG BioMed US Inc. All testing is performed exclusively in our CLIA-certified and CAP-accredited laboratory. The analytical performance of the test has been validated to support reliable results.